Mercaptopurine 71921-0150
Product NDC
71921-0150- Manufacturer
- Florida Pharmaceutical Products, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 30, 2026
- Listing Expires
- December 31, 2027
- Application
- NDA009053
Need to source Mercaptopurine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mercaptopurine | 50 mg/1 |
Drug Class
Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(2)
25 TABLET in 1 BOTTLE (71921-150-02)
250 TABLET in 1 BOTTLE (71921-150-25)